N. Doldi et al., VASCULAR ENDOTHELIAL GROWTH-FACTOR MESSENGER-RIBONUCLEIC-ACID EXPRESSION IN HUMAN OVARIAN AND ENDOMETRIAL CANCER, Gynecological endocrinology, 10(6), 1996, pp. 375-382
Vascular endothelial growth factor (VEGF) is a previously discovered a
ngiogenic factor that seems to influence the neoangiogenesis of neopla
stic and non-neoplastic tissues. Substantial experimental evidence lin
ks tumor growth and metastasis with blood vessel formation. Tumor angi
ogenesis can be induced by factors released by the tumor cells themsel
ves. A variety of transformed cell lines expresses the VEGF transcript
and secretes an EGF-like protein, suggesting that this angiogenic fac
tor may be one of the mediators of tumor angiogenesis. By Northern blo
t analysis and in situ hybridization, we investigated the expression o
f VEGF transcript in human ovarian and endometrial neoplasms. Messenge
r RNA encoding VEGF was detected in all tissues studied and was more d
ensely expressed in endometrial carcinoma. VEGF expression was also id
entified in cells obtained from ovarian and endometrial ascitic plain
VEGF mRNA, detected by in situ hybridization, was identified in the ep
ithelial cells of endometrial adenocarcinoma. This distribution was lo
calized primarily in the al,ices of the papillae. The prominence of VE
GF mRNA levels in human ovarian and endometrial tumors demonstrates th
at VEGF may be involved in promoting turner angiogenesis and stroma ge
neration, acting as an endothelial cell mitogen.